EQT agrees to take over QIAGEN in an all-cash offer
The all-cash takeover uses EQT XI fund. The deal represents initial investment for the EUR 23 billion target fund.
See the latest news and media coverage for EQT. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global private markets firm
eqtgroup.comLast updated
In short: EQT agreed QIAGEN, Cleanaway, and Stockbridge takeovers, completed the Coller Capital deal, and launched new funds.
The all-cash takeover uses EQT XI fund. The deal represents initial investment for the EUR 23 billion target fund.
The acquisition includes a 32.1% premium to the last closing share price, with completion expected by March 2027.
The firm acquired Coller Capital and launched a Middle East office while reporting €41.6bn in gross inflows and strong fundraising momentum for new strategies.
The deal exits Warburg Pincus while retaining founder-led management. EQT plans to accelerate global expansion, talent recruitment, and digital innovation by mid-2027.
In June, it accepted a GBP9.5 billion takeover offer from Luxembourg-based EQT Fund Management Sarl. The offer, made through bid vehicle Isotope Bidco Ltd, values...
Linklaters, Davis Polk & Wardwell, and Benelux firm De Brauw are advising Netherlands-headquartered Qiagen, which they also advised on Thermo Fisher’s failed $11.5 billion bid...
European molecular testing company Qiagen is in advanced talks to be acquired by Swedish buyout firm EQT , Bloomberg News reported on Tuesday, citing people...
Bank of America reiterates buy recommendation and increases target price after Q3 update, raising profit forecasts by 2-4 percent.
Track EQT and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to EQT and other trending companies.